Directed evolution of a virus exclusively utilizing human epidermal growth factor receptor as the entry receptor

Journal of Virology

Volumn 87, Issue 20, 2013, Pages 11231-11243

  Dai, Hong Sheng ^a,b   Liu, Zheng ^a   Jiang, Wen ^a   Kuhna, Richard J ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CELL RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; STRUCTURAL PROTEIN; VIRUS RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; BIOENGINEERING; CONTROLLED STUDY; CRYOELECTRON MICROSCOPY; DIRECTED EVOLUTION; EPIDERMAL GROWTH FACTOR RECEPTOR SPECIFIC VIRUS 1; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SINDBIS VIRUS; TANDEM SELECTION AND ENRICHMENT SYSTEM; VIRUS; VIRUS ENTRY; VIRUS MORPHOLOGY;

CELL LINE; CRYOELECTRON MICROSCOPY; DIRECTED MOLECULAR EVOLUTION; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, VIRUS; SELECTION, GENETIC; SINDBIS VIRUS; VIRION; VIROLOGY; VIRUS ATTACHMENT;

EID: 84886933967     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01054-13     Document Type: Article

References (45)

1. Jäckel C, Kast P, Hilvert D. 2008. Protein design by directed evolution. Annu. Rev. Biophys. 37:153-173.
2. Park HS, Nam SH, Lee JK, Yoon CN, Mannervik B, Benkovic SJ, Kim HS. 2006. Design and evolution of new catalytic activity with an existing protein scaffold. Science 311:535-538.
3. Sarkar I, Hauber I, Hauber J, Buchholz F. 2007. HIV-1 proviral DNA excision using an evolved recombinase. Science 316:1912-1915.
4. Fleishman SJ, Whitehead TA, Ekiert DC, Dreyfus C, Corn JE, Strauch EM, Wilson IA, Baker D. 2011. Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science 332: 816-821.
5. Romero PA, Arnold FH. 2009. Exploring protein fitness landscapes by directed evolution. Nat. Rev. Mol. Cell Biol. 10:866-876.
6. Wörsdörfer B, Woycechowsky KJ, Hilvert D. 2011. Directed evolution of a protein container. Science 331:589-592.
7. King NP, Sheffler W, Sawaya MR, Vollmar BS, Sumida JP, Andre I, Gonen T, Yeates TO, Baker D. 2012. Computational design of selfassembling protein nanomaterials with atomic level accuracy. Science 336: 1171-1174.
8. Heo J, Reid T, Ruo L, Breitbach CJ, Rose S, Bloomston M, Cho M, Lim HY, Chung HC, Kim CW, Burke J, Lencioni R, Hickman T, Moon A, Lee YS, Kim MK, Daneshmand M, Dubois K, Longpre L, Ngo M, Rooney C, Bell JC, Rhee BG, Patt R, Hwang TH, Kirn DH. 2013. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat. Med. 19:329-336.
9. Breitbach CJ, Burke J, Jonker D, Stephenson J, Haas AR, Chow LQ, Nieva J, Hwang TH, Moon A, Patt R, Pelusio A, Le Boeuf F, Burns J, Evgin L, De Silva N, Cvancic S, Robertson T, Je JE, Lee YS, Parato K, Diallo JS, Fenster A, Daneshmand M, Bell JC, Kirn DH. 2011. Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature 477:99-102.
10. Helenius A. 2007. Virus entry and uncoating, p 99-118. In Fields BN, Knipe DM, HowleyPM(ed), Fields virology, 5th ed, vol 1. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PA.
11. Cattaneo R, Miest T, Shashkova EV, Barry MA. 2008. Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. Nat. Rev. Microbiol. 6:529-540.
12. Yarden Y, Pines G. 2012. The ERBB network: at last, cancer therapy meets systems biology. Nat. Rev. Cancer 12:553-563.
13. Ciardiello F, Tortora G. 2008. EGFR antagonists in cancer treatment. N. Engl. J. Med. 358:1160-1174.
14. Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, Saito K, Sakamoto A, Inoue M, Shirouzu M, Yokoyama S. 2002. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110:775-787.
15. Sorkin A, Duex JE. 2010. Quantitative analysis of endocytosis and turnover of epidermal growth factor (EGF) and EGF receptor. Curr. Protoc. Cell Biol. Chapter 15: Unit 15.14.
16. Campos SK, Barry MA. 2007. Current advances and future challenges in adenoviral vector biology and targeting. Curr. Gene Ther. 7:189-204.
17. Davis CW, Nguyen HY, Hanna SL, Sanchez MD, Doms RW, Pierson TC. 2006. West Nile virus discriminates between DC-SIGN and DCSIGNR for cellular attachment and infection. J. Virol. 80:1290-1301.
18. Rice CM, Levis R, Strauss JH, Huang HV. 1987. Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants. J. Virol. 61:3809-3819.
19. Owen KE, Kuhn RJ. 1996. Identification of a region in the Sindbis virus nucleocapsid protein that is involved in specificity of RNA encapsidation. J. Virol. 70:2757-2763.
20. Navaratnarajah CK. 2006. Functional characterization of the alphavirus E2 glycoprotein: a guide to host range modification. Purdue University, West Lafayette, IN.
21. Tang J, Jose J, Chipman P, Zhang W, Kuhn RJ, Baker TS. 2011. Molecular links between the E2 envelope glycoprotein and nucleocapsid core in Sindbis virus. J. Mol. Biol. 414:442-459.
22. Ludtke SJ, Baldwin PR, Chiu W. 1999. EMAN: semiautomated software for high-resolution single-particle reconstructions. J. Struct. Biol. 128:82-97.
23. Yang C, Jiang W, Chen DH, Adiga U, Ng EG, Chiu W. 2009. Estimating contrast transfer function and associated parameters by constrained nonlinear optimization. J. Microsc. 233:391-403.
24. Rosenthal PB, Henderson R. 2003. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 333:721-745.
25. Navaza J, Lepault J, Rey FA, Alvarez-Rua C, Borge J. 2002. On the fitting of model electron densities into EM reconstructions: a reciprocal-space formulation. Acta Crystallogr. D Biol. Crystallogr. 58:1820-1825.
26. Tseng J-C, Levin B, Hurtado A, Yee H, de Castro IP, Jimenez M, Shamamian P, Jin R, Novick RP, Pellicer A, Meruelo D. 2004. Systemic tumor targeting and killing by Sindbis viral vectors. Nat. Biotechnol. 22: 70-77.
27. Strauss JH, Strauss EG. 1994. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 58:491-562.
28. Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E, Thompson A, Bricogne G, Rey FA. 2010. Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature 468:709-712.
29. Li L, Jose J, Xiang Y, Kuhn RJ, Rossmann MG. 2010. Structural changes of envelope proteins during alphavirus fusion. Nature 468:705-708.
30. Castro C, Arnold JJ, Cameron CE. 2005. Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective. Virus Res. 107:141-149.
31. Tamberg N, Lulla V, Fragkoudis R, Lulla A, Fazakerley JK, Merits A. 2007. Insertion of EGFP into the replicase gene of Semliki Forest virus results in a novel, genetically stable marker virus. J. Gen. Virol. 88:1225-1230.
32. Klimstra WB, Ryman KD, Johnston RE. 1998. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J. Virol. 72:7357-7366.
33. Rose PP, Hanna SL, Spiridigliozzi A, Wannissorn N, Beiting DP, Ross SR, Hardy RW, Bambina SA, Heise MT, Cherry S. 2011. Natural resistance-associated macrophage protein is a cellular receptor for Sindbis virus in both insect and mammalian hosts. Cell Host Microbe 10:97-104.
34. Wang KS, Kuhn RJ, Strauss EG, Ou S, Strauss JH. 1992. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J. Virol. 66:4992-5001.
35. Klimstra WB, Nangle EM, Smith MS, Yurochko AD, Ryman KD. 2003. DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses. J. Virol. 77:12022-12032.
36. Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD. 2007. MDA-MB-435 cells are derived from M14 melanoma cells-a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res. Treat. 104:13-19.
37. Longva KE, Blystad FD, Stang E, Larsen AM, Johannessen LE, Madshus IH. 2002. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J. Cell Biol. 156:843-854.
38. Byrnes AP, Griffin DE. 1998. Binding of Sindbis virus to cell surface heparan sulfate. J. Virol. 72:7349-7356.
39. Rini JM, Esko JD, Varki A. 2009. Glycosyltransferases and glycanprocessing enzymes, p 63-74. In Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (ed), Essentials of glycobiology, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
40. Guo F, Jiang W. Single particle cryo-electron microscopy and 3-D reconstruction of viruses. In Kuo J (ed), Methods in molecular biology: electron microscopy, in press. Humana Press, New York, NY.
41. Jang JH, Lim KI, Schaffer DV. 2007. Library selection and directed evolution approaches to engineering targeted viral vectors. Biotechnol. Bioeng. 98:515-524.
42. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420-428.
43. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534-1541.
44. Maheshri N, Koerber JT, Kaspar BK, Schaffer DV. 2006. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat. Biotechnol. 24:198-204.
45. Jiang W, Guo F, Liu Z. 2012. A graph theory method for determination of cryo-EM image focuses. J. Struct. Biol. 180:343-351.